ES2121065T3 - Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion. - Google Patents
Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion.Info
- Publication number
- ES2121065T3 ES2121065T3 ES93400279T ES93400279T ES2121065T3 ES 2121065 T3 ES2121065 T3 ES 2121065T3 ES 93400279 T ES93400279 T ES 93400279T ES 93400279 T ES93400279 T ES 93400279T ES 2121065 T3 ES2121065 T3 ES 2121065T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- blood plasma
- pasteurizing
- procedure
- plasma during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMPOSICION DESTINADA A ESTABILIZAR EL PLASMA SANGUINEO, TOTAL O DESPROVISTO DE CRIOPROTEINAS, EN PROCESO DE PASTEURIZACION. LA COMPOSICION SEGUN LA INVENCION PERMITE PASTEURIZAR MUY GRANDES VOLUMENES DE PLASMA (DEL ORDEN DE 60 LITROS). LA INVENCION SE REFIERE TAMBIEN AL PROCESO DE PASTEURIZACION QUE UTILIZA LA COMPOSICION ESTABILIZANTE. EL PLASMA PASTEURIZADO OBTENIDO SE DESTINA A UN USO TERAPEUTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9201604A FR2687317B1 (fr) | 1992-02-13 | 1992-02-13 | Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2121065T3 true ES2121065T3 (es) | 1998-11-16 |
Family
ID=9426597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93400279T Expired - Lifetime ES2121065T3 (es) | 1992-02-13 | 1993-02-04 | Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0556096B1 (es) |
JP (2) | JP4010573B2 (es) |
AT (1) | ATE171074T1 (es) |
BR (1) | BR9300524A (es) |
CA (1) | CA2089446C (es) |
CZ (1) | CZ285573B6 (es) |
DE (1) | DE69321007T2 (es) |
DK (1) | DK0556096T3 (es) |
EE (1) | EE03091B1 (es) |
ES (1) | ES2121065T3 (es) |
FI (1) | FI103380B (es) |
FR (1) | FR2687317B1 (es) |
HU (1) | HU210026B (es) |
LT (1) | LT3226B (es) |
LV (1) | LV10195B (es) |
NO (1) | NO306532B1 (es) |
PL (1) | PL174098B1 (es) |
RU (1) | RU2112522C1 (es) |
SK (1) | SK280665B6 (es) |
UA (1) | UA27102C2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9501189D0 (sv) * | 1995-03-31 | 1995-03-31 | Pharmacia Ab | Protein formulation |
US5616159A (en) * | 1995-04-14 | 1997-04-01 | Corning Incorporated | Method of forming high purity fused silica having high resistance to optical damage |
US6619073B2 (en) | 1996-03-05 | 2003-09-16 | Corning Incorporated | Method of increasing the initial transmittance of optical glass |
US5962213A (en) * | 1996-06-14 | 1999-10-05 | Biostore New Zealand Limited | Compositions and methods for the preservation of living tissues |
US6361933B1 (en) | 1996-06-14 | 2002-03-26 | Biostore New Zealand Limited | Solutions for the preservation of tissues |
US5827640A (en) * | 1996-06-14 | 1998-10-27 | Biostore New Zealand Limited | Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose |
US6037116A (en) * | 1996-06-14 | 2000-03-14 | Biostore New Zealand, Ltd. | Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials |
AU725247B2 (en) * | 1996-06-14 | 2000-10-12 | Biostore New Zealand Limited | Compositions and methods for the preservation of living tissues |
US6114107A (en) * | 1996-06-14 | 2000-09-05 | Biostore New Zealand Limited | Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues |
US5879875A (en) * | 1996-06-14 | 1999-03-09 | Biostore New Zealand | Compositions and methods for the preservation of living tissues |
US6915665B2 (en) | 2000-10-31 | 2005-07-12 | Corning Incorporated | Method of inducing transmission in optical lithography preforms |
US20060019234A1 (en) * | 2004-07-22 | 2006-01-26 | Shanbrom Technologies, Llc | Modern blood banking employing improved cell preservation composition |
ES2264403B1 (es) * | 2006-06-22 | 2007-11-01 | Grifols S.A. | Medio de suspension de hematies. |
DE102011056142A1 (de) * | 2011-12-07 | 2013-06-13 | Manfred Rüdinger | Metabolisierbare Salze und deren Verwendung in Diagnostik und Therapie |
RU2639446C1 (ru) * | 2016-11-23 | 2017-12-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ хранения плазмы крови, содержащей лекарственные вещества с нестабильными фенольными гидроксилами |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
DE3230849A1 (de) * | 1982-08-19 | 1984-02-23 | Behringwerke Ag, 3550 Marburg | Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung |
DE3237512A1 (de) * | 1982-10-09 | 1984-04-12 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat |
US4470968A (en) * | 1983-01-13 | 1984-09-11 | Miles Laboratories, Inc. | Pasteurized therapeutically active blood coagulation factor concentrates |
JPS59134730A (ja) * | 1983-01-20 | 1984-08-02 | Green Cross Corp:The | 血液凝固第8因子の加熱処理法 |
DE3330770A1 (de) * | 1983-08-26 | 1985-03-14 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von humanplasma |
FR2650508A1 (fr) * | 1989-08-01 | 1991-02-08 | Fondation Nale Transfusion San | Colle pasteurisee pour reunir des tissus humain ou animal |
FR2664165B1 (fr) | 1990-07-03 | 1992-10-16 | Lille Transfusion Sanguine | Composition pour stabiliser le plasma sanguin en cours de pasteurisation. |
-
1992
- 1992-02-13 FR FR9201604A patent/FR2687317B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-04 AT AT93400279T patent/ATE171074T1/de not_active IP Right Cessation
- 1993-02-04 DE DE69321007T patent/DE69321007T2/de not_active Expired - Lifetime
- 1993-02-04 ES ES93400279T patent/ES2121065T3/es not_active Expired - Lifetime
- 1993-02-04 DK DK93400279T patent/DK0556096T3/da active
- 1993-02-04 EP EP93400279A patent/EP0556096B1/fr not_active Expired - Lifetime
- 1993-02-09 BR BR9300524A patent/BR9300524A/pt not_active Application Discontinuation
- 1993-02-09 CZ CZ93161A patent/CZ285573B6/cs not_active IP Right Cessation
- 1993-02-10 SK SK82-93A patent/SK280665B6/sk not_active IP Right Cessation
- 1993-02-10 LV LVP-93-113A patent/LV10195B/en unknown
- 1993-02-11 NO NO930473A patent/NO306532B1/no not_active IP Right Cessation
- 1993-02-11 PL PL93297699A patent/PL174098B1/pl not_active IP Right Cessation
- 1993-02-12 FI FI930630A patent/FI103380B/fi not_active IP Right Cessation
- 1993-02-12 JP JP04609393A patent/JP4010573B2/ja not_active Expired - Fee Related
- 1993-02-12 HU HU9300377A patent/HU210026B/hu not_active IP Right Cessation
- 1993-02-12 LT LTIP338A patent/LT3226B/lt not_active IP Right Cessation
- 1993-02-12 CA CA002089446A patent/CA2089446C/fr not_active Expired - Fee Related
- 1993-06-15 UA UA93002940A patent/UA27102C2/uk unknown
-
1994
- 1994-05-23 EE EE9400005A patent/EE03091B1/xx not_active IP Right Cessation
-
1998
- 1998-02-12 RU RU93004727A patent/RU2112522C1/ru not_active IP Right Cessation
-
2006
- 2006-08-02 JP JP2006211141A patent/JP4472672B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2121065T3 (es) | Composicion para estabilizar el plasma sanguineo durante el pasteurizado y procedimiento de pasteurizado que comprende la utilizacion de esta composicion. | |
DE69527723T2 (de) | Femoraler marknagel | |
BG100910A (en) | The use of bisphosphonates for the inhibition of osteal resorption after the implantation of orthopedic prosthesis | |
ATE449581T1 (de) | System zur minimalinvasiven einführung einer herzklappen- bioprothese | |
RU93004727A (ru) | Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии | |
DE69535453D1 (de) | Zusammensetzungen zur Verbesserung der Immunantwort | |
PL294037A1 (en) | Composition for stabilizing blood plsma during pasteurization | |
IL89901A0 (en) | Strobilurine derivatives | |
DE59400836D1 (de) | Flüssiggasformulierung zur Vitalitätsprüfung von Zähnen | |
GEP19991579B (en) | Method for Shunting of Arteries | |
SE8404774D0 (sv) | Forfarande for kontinuerlig behandling av naturlig gredde genom sterilisering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 556096 Country of ref document: ES |